ERYTHROMYCIN ETHYLSUCCINATE
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for ERYTHROMYCIN ETHYLSUCCINATE, covering 2006-08-10 to 2022-11-21. Get the full timeline:
Most recent: FDA Approved: ERYTHROMYCIN ETHYLSUCCINATE — Original Application (Cadila Pharmaceuticals Limited)